Maxime Barakat, MD, PhD, MBA
Bausch Health, Montreal, QC
Dr. Maxime Barakat is an accomplished medical professional with more than 20 years of experience in the pharmaceutical industry. He is currently the Head and Vice-president of International Medical and Clinical Affairs at Bausch Health Companies (BHC), a global pharmaceutical company.
Dr. Barakat received his Doctorate in Medicine (MD) from a medical institute in Ukraine in 1990. After moving to Canada in 1993, he passed the evaluation examination of the Medical Council of Canada and was granted his MD recognition.
Dr. Barakat continued his education and research, and in 2003, he received his Doctorate in Pharmacology (Ph.D.) from the University of Montreal. In 2019, he completed an Executive MBA from the School of Sciences Management at UQAM in Montreal and the University of Paris Dauphine in Paris.
Dr. Barakat has held a variety of positions in the pharmaceutical industry, including Medical Director at Bristol-Myers Squibb, Manager and Associate Director of Market Access at Bristol-Myers Squibb, and Vice-president of Axiome Communications. He has also served as an invited speaker on drug development at the University of Montreal, Canada.
In his current role at Bausch Health, Dr. Barakat is responsible for leading the company's international medical and clinical affairs activities. He is also responsible with his international teams for developing and implementing the company's medical strategy.
NOV 2 (Thu)
Visualizing Skin Health: Navigating The State of Dermatoimaging in 2023
In this presentation, two teledermatology experts will give a thorough overview of Dermatoimaging. They will cover its techniques, advanced methods, best practices, and how artificial intelligence and machine learning are being used to deploy and assess skin images. The speakers will explain how these technologies aid in image analysis, diagnosis, and pattern recognition, ultimately enhancing clinical decision-making. Additionally, they will discuss the innovative applications of Dermatoimaging, such as monitoring treatment progress, teledermatology, and data-driven research advancements.
In collaboration with: